DD298948A5 - Neue cytokine - Google Patents
Neue cytokine Download PDFInfo
- Publication number
- DD298948A5 DD298948A5 DD90342467A DD34246790A DD298948A5 DD 298948 A5 DD298948 A5 DD 298948A5 DD 90342467 A DD90342467 A DD 90342467A DD 34246790 A DD34246790 A DD 34246790A DD 298948 A5 DD298948 A5 DD 298948A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- dna
- derivative
- antibody
- giu
- lys
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Control Of Transmission Device (AREA)
- Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
- Radar Systems Or Details Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898915414A GB8915414D0 (en) | 1989-07-05 | 1989-07-05 | Novel cytokines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD298948A5 true DD298948A5 (de) | 1992-03-19 |
Family
ID=10659582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD90342467A DD298948A5 (de) | 1989-07-05 | 1990-07-03 | Neue cytokine |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5411882A (pt) |
| EP (1) | EP0412050B1 (pt) |
| JP (1) | JPH0356499A (pt) |
| AT (1) | ATE131873T1 (pt) |
| AU (1) | AU649226B2 (pt) |
| CA (1) | CA2020303A1 (pt) |
| DD (1) | DD298948A5 (pt) |
| DE (1) | DE69024279T2 (pt) |
| DK (1) | DK0412050T3 (pt) |
| ES (1) | ES2081960T3 (pt) |
| GB (1) | GB8915414D0 (pt) |
| GR (1) | GR3018521T3 (pt) |
| IE (1) | IE70519B1 (pt) |
| PT (1) | PT94575B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2052602T3 (es) * | 1986-10-03 | 1994-07-16 | Ciba Geigy Ag | Nuevos peptidos afines a las linfocinas. |
| ATE311895T1 (de) | 1992-05-26 | 2005-12-15 | Immunex Corp | Neue zytokine die cd30 binden |
| US6645493B1 (en) * | 1993-05-17 | 2003-11-11 | The Picower Institute For Medical Research | Composition containing anti-MIF antibody |
| US6774227B1 (en) * | 1993-05-17 | 2004-08-10 | Cytokine Pharmasciences, Inc. | Therapeutic uses of factors which inhibit or neutralize MIF activity |
| UY27304A1 (es) | 2001-05-24 | 2002-12-31 | Avanir Pharmaceuticals | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación |
| TW200418829A (en) | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| CN1839133A (zh) * | 2003-08-22 | 2006-09-27 | 阿文尼尔药品公司 | 作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用 |
| WO2006068398A1 (en) | 2004-12-20 | 2006-06-29 | Isu Abxis Co., Ltd. | Molecules inhibition intercellular adhesion |
| US7740856B2 (en) * | 2005-12-20 | 2010-06-22 | Isu Abxis Co., Ltd. | Effect of BST2 on inflammation |
| US8329186B2 (en) * | 2004-12-20 | 2012-12-11 | Isu Abxis Co., Ltd | Treatment of inflammation using BST2 inhibitor |
| US20080299128A1 (en) * | 2006-06-20 | 2008-12-04 | Myung Kim | Effect of Bst2 on inflammation |
| WO2006102191A1 (en) * | 2005-03-24 | 2006-09-28 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| MXPA05011139A (es) * | 2005-10-17 | 2007-04-17 | Concretos Translucidos S De R | Formulacion para obtener una mezcla de concreto conductivo. |
| GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
| US9249217B2 (en) * | 2010-12-03 | 2016-02-02 | Secretary, DHHS | Bispecific EGFRvIII x CD3 antibody engaging molecules |
| US9958456B2 (en) | 2011-10-07 | 2018-05-01 | Baxalta Incorporated | OxMIF as a diagnostic marker |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0672158B2 (ja) * | 1984-05-24 | 1994-09-14 | チバ−ガイギ− アクチエンゲゼルシヤフト | 精製されたヒトマクロファージ遊走阻止因子 |
| US5008374A (en) * | 1986-03-14 | 1991-04-16 | Otsuka Pharmaceutical Co., Ltd. | IL-1α derivatives and drugs |
| ES2052602T3 (es) * | 1986-10-03 | 1994-07-16 | Ciba Geigy Ag | Nuevos peptidos afines a las linfocinas. |
| ATE149176T1 (de) * | 1987-10-02 | 1997-03-15 | Univ Rockefeller | Von makrophagen abstammender entzündungsvermittler(mip-1-alpha et mip-1-beta) |
-
1989
- 1989-07-05 GB GB898915414A patent/GB8915414D0/en active Pending
-
1990
- 1990-06-26 DK DK90810481.3T patent/DK0412050T3/da active
- 1990-06-26 AT AT90810481T patent/ATE131873T1/de not_active IP Right Cessation
- 1990-06-26 ES ES90810481T patent/ES2081960T3/es not_active Expired - Lifetime
- 1990-06-26 EP EP90810481A patent/EP0412050B1/en not_active Expired - Lifetime
- 1990-06-26 DE DE69024279T patent/DE69024279T2/de not_active Expired - Fee Related
- 1990-07-02 AU AU58095/90A patent/AU649226B2/en not_active Ceased
- 1990-07-03 PT PT94575A patent/PT94575B/pt not_active IP Right Cessation
- 1990-07-03 DD DD90342467A patent/DD298948A5/de not_active IP Right Cessation
- 1990-07-03 CA CA002020303A patent/CA2020303A1/en not_active Abandoned
- 1990-07-04 IE IE242690A patent/IE70519B1/en not_active IP Right Cessation
- 1990-07-05 JP JP2176488A patent/JPH0356499A/ja active Pending
-
1991
- 1991-12-20 US US07/811,893 patent/US5411882A/en not_active Expired - Fee Related
-
1995
- 1995-12-21 GR GR950403656T patent/GR3018521T3/el unknown
-
1996
- 1996-09-27 US US08/714,927 patent/US5821336A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0356499A (ja) | 1991-03-12 |
| AU5809590A (en) | 1991-01-10 |
| PT94575B (pt) | 1997-02-28 |
| ATE131873T1 (de) | 1996-01-15 |
| EP0412050A1 (en) | 1991-02-06 |
| IE70519B1 (en) | 1996-12-11 |
| IE902426A1 (en) | 1991-06-19 |
| ES2081960T3 (es) | 1996-03-16 |
| DE69024279T2 (de) | 1996-10-17 |
| AU649226B2 (en) | 1994-05-19 |
| GB8915414D0 (en) | 1989-08-23 |
| GR3018521T3 (en) | 1996-03-31 |
| DE69024279D1 (de) | 1996-02-01 |
| PT94575A (pt) | 1991-03-20 |
| EP0412050B1 (en) | 1995-12-20 |
| US5411882A (en) | 1995-05-02 |
| US5821336A (en) | 1998-10-13 |
| DK0412050T3 (da) | 1996-01-29 |
| CA2020303A1 (en) | 1991-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69233421T2 (de) | Neuartige rezeptor-typ tyrosinkinase und deren verwendung | |
| EP2400018B1 (de) | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung | |
| DE3588219T2 (de) | T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide | |
| DE3752360T2 (de) | Menschliche DNS zum Nachweis von Retinoblastoma | |
| DD298948A5 (de) | Neue cytokine | |
| DE69302234T2 (de) | Menschliches Prohibitin und Prohibitin kodierende DNS | |
| DE3855359T2 (de) | Seniles amyloides Vorläufer-Protein und dafür spezifischer Antikörper | |
| DE69230136T2 (de) | Cytokin-induziertes protein, tsg-6, seine dna und verwendung | |
| DE3853842T2 (de) | Wachstumsregler zusammenhängend mit Blutplättchen. | |
| DE69029970T2 (de) | Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen | |
| EP1483389B1 (de) | Differentiell in tumoren exprimierte genprodukte und deren verwendung | |
| DE3750379T3 (de) | Varianten des abbaubeschleunigenden Faktors (DAF), hergestellt durch rekombinante DNS-Technologie. | |
| DE69029294T2 (de) | Nichtmenschliche primaten CD4-Polypeptide und menschliche glykosilierbare CD4-Moleküle | |
| DE69832539T2 (de) | Polypeptid und dafür kodierendes Nukeinsäure | |
| DE69226448T2 (de) | Glykoprotein komplexe und glykoproteine | |
| DE69535316T2 (de) | Als lerk6 bezeichnetes cytokin | |
| DE69233155T2 (de) | Insulinartigen wachstumsfaktor bindendes protein | |
| DE69925271T2 (de) | Angiostatin-bindendes protein | |
| EP0805204B1 (de) | Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung | |
| DE68918479T2 (de) | Menschlicher Hitzeschock-Faktor. | |
| DE2804567C2 (de) | Pentapeptide, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3650641T2 (de) | Peptidfragment des menschlichen Villins und Antikörper dagegen | |
| DE60016398T2 (de) | Tumorsuppressorgen | |
| DE10305082A1 (de) | MIA-2 Protein | |
| DE69829417T2 (de) | Polypeptide und dafür kodierende Nukleinsäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |